Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Notes on buspirone's mechanisms of action.

S Garattini, S Caccia, T Mennini

    The Journal of Clinical Psychiatry
    |December 1, 1982
    PubMed
    Summary

    Buspirone, a psychotropic drug, exhibits anxiolytic effects. Its metabolite, 1-PP, may be responsible for its anticonflict activity in rats, potentially by interacting with benzodiazepine-GABA receptors.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    An Atypical Case of Idiopathic Nonhistaminergic Angioedema With Anti-C1-INH Antibodies.

    Journal of investigational allergology & clinical immunology·2022
    Same author

    Ingestion and effects of polystyrene nanoparticles in the silkworm Bombyx mori.

    Chemosphere·2020
    Same author

    Novelties in the Diagnosis and Treatment of Angioedema.

    Journal of investigational allergology & clinical immunology·2016
    Same author

    Hepatic fibrinogen storage disease: identification of two novel mutations (p.Asp316Asn, fibrinogen Pisa and p.Gly366Ser, fibrinogen Beograd) impacting on the fibrinogen γ-module.

    Journal of thrombosis and haemostasis : JTH·2015
    Same author

    The spectrum of factor XI deficiency in Italy.

    Haemophilia : the official journal of the World Federation of Hemophilia·2013
    Same author

    [Medical humanities in gynecology and obstetrics].

    Minerva ginecologica·2012

    Area of Science:

    • Neuroscience
    • Pharmacology

    Background:

    • Buspirone is a novel psychotropic drug with demonstrated anxiolytic effects in humans.
    • Buspirone exhibits distinct neurochemical properties compared to neuroleptics and benzodiazepines.
    • Buspirone undergoes extensive metabolism, producing several brain-penetrant metabolites, including 1-PP.

    Purpose of the Study:

    • To investigate the neurochemical mechanisms underlying buspirone's anxiolytic and anticonflict activities.
    • To explore the role of buspirone metabolites, particularly 1-PP, in its pharmacological effects.
    • To compare the neurochemical profile of buspirone with established psychotropic medications.

    Main Methods:

    • The study likely involved animal models (rats) to assess anticonflict activity.
    • Neurochemical analyses were performed to quantify buspirone and its metabolites in the brain.
    • Pharmacological assays may have been used to evaluate interactions with neurotransmitter systems, such as the dopaminergic system and benzodiazepine-GABA receptors.

    Main Results:

    • 1-PP, a major buspirone metabolite, achieves higher brain concentrations than the parent drug, especially after oral administration.
    • Buspirone's anticonflict activity in rats may be partially mediated by 1-PP.
    • These effects appear to occur independently of dopaminergic system modulation.

    Conclusions:

    • The metabolite 1-PP is a significant factor in buspirone's anticonflict effects.
    • Buspirone and its metabolite 1-PP might interact with benzodiazepine-GABA receptors, potentially mimicking benzodiazepine actions.
    • Further research is warranted to elucidate the precise interactions at the molecular level.

    Related Experiment Videos